TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 83 filers reported holding TANGO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,741,618 | +271.4% | 154,673 | +9.5% | 0.00% | – |
| Q2 2023 | $468,967 | -16.0% | 141,255 | -0.1% | 0.00% | – |
| Q1 2023 | $558,546 | -47.4% | 141,404 | -3.4% | 0.00% | – |
| Q4 2022 | $1,061,045 | +97.6% | 146,351 | -1.2% | 0.00% | – |
| Q3 2022 | $537,000 | -11.7% | 148,196 | +10.3% | 0.00% | – |
| Q2 2022 | $608,000 | +218.3% | 134,384 | +432.8% | 0.00% | – |
| Q1 2022 | $191,000 | -30.8% | 25,221 | 0.0% | 0.00% | – |
| Q4 2021 | $276,000 | -15.3% | 25,221 | 0.0% | 0.00% | – |
| Q3 2021 | $326,000 | – | 25,221 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 19,363,975 | $211,842,000 | 60.92% |
| Cormorant Asset Management, LP | 4,899,185 | $53,149,000 | 3.16% |
| Boxer Capital, LLC | 6,871,642 | $75,176,000 | 2.92% |
| Casdin Capital, LLC | 5,487,910 | $60,038,000 | 1.69% |
| Bain Capital Life Sciences Investors, LLC | 1,921,790 | $21,024,000 | 1.67% |
| Samsara BioCapital, LLC | 630,000 | $6,892,000 | 1.34% |
| TANG CAPITAL MANAGEMENT LLC | 468,750 | $5,128,000 | 1.03% |
| HARVARD MANAGEMENT CO INC | 708,385 | $7,750,000 | 0.73% |
| HHLR ADVISORS, LTD. | 3,873,982 | $42,381,000 | 0.66% |
| Southpoint Capital Advisors LP | 3,000,000 | $32,820,000 | 0.63% |